Effect of Weight Reduction on Metabolic Parameters in Subjects after Atrial Fibrillation Ablation (HOBIT-FD Trial). Poster
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023001%3A_____%2F25%3A00086025" target="_blank" >RIV/00023001:_____/25:00086025 - isvavai.cz</a>
Result on the web
—
DOI - Digital Object Identifier
—
Alternative languages
Result language
angličtina
Original language name
Effect of Weight Reduction on Metabolic Parameters in Subjects after Atrial Fibrillation Ablation (HOBIT-FD Trial). Poster
Original language description
Obesity is an established risk factor for atrial fibrillation (AF). Cardiac ablation(CA) is a treatment option following the failure of cardioversion or pharmacotherapy.However, AF recurrence occurs in up to 40% of patients, with those who are obese at higherrisk. This study aims to assess the impact of weight reduction on metabolic parameters inpatients after atrial fibrillation ablation.
Czech name
—
Czech description
—
Classification
Type
O - Miscellaneous
CEP classification
—
OECD FORD branch
30202 - Endocrinology and metabolism (including diabetes, hormones)
Result continuities
Project
<a href="/en/project/LX22NPO5104" target="_blank" >LX22NPO5104: National Institute for Research of Metabolic and Cardiovascular Diseases</a><br>
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)
Others
Publication year
2025
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů